Substance Abuse Treatment Market Share, Size, Trends, Industry Analysis Report, By Treatment Type (Drug Abuse, Alcohol, Tobacco/Nicotine, Others); By End-Use; By Region; Segment Forecast, 2023 - 2032

Substance Abuse Treatment Market Share, Size, Trends, Industry Analysis Report, By Treatment Type (Drug Abuse, Alcohol, Tobacco/Nicotine, Others); By End-Use; By Region; Segment Forecast, 2023 - 2032

The global substance abuse treatment market size is expected to reach USD 22.01 billion by 2032, according to a new study by Polaris Market Research. The report “Substance Abuse Treatment Market Share, Size, Trends, Industry Analysis Report, By Treatment Type (Drug Abuse, Alcohol, Tobacco/Nicotine, Others); By End-Use; By Region; Segment Forecast, 2023 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

As the demand for effective and affordable substance abuse treatments grows, the healthcare industry strives to develop new and innovative addiction treatment therapies. This is reflected in the increasing research and development activities in this field. For instance, the National Institute on Drug Abuse (NIDA) in the U.S. spent over $1.3 billion on addiction research, including studies on developing new treatments.

In addition, the global concern for substance abuse has led to increased efforts to raise awareness about its ill effects and prevention among people. According to the World Health Organization (WHO), around 35 million people worldwide suffer from drug use disorders. This alarming statistic has led to a rise in the number of addiction treatment centers across the globe.

Drug treatment aims to assist individuals with addiction in ceasing compulsive drug use and addictive behaviors. Treatment can be provided in various environments, using diverse modalities, and may vary in duration. As drug addiction is a chronic condition often marked by occasional relapses, short-term or one-time treatment is often insufficient. Sometimes, treatment is a lengthy process requiring frequent monitoring and multiple interventions.

There is an increasing demand for evidence-based treatment approaches, leading to the development of new therapies and treatment options, such as medication-assisted treatment and behavioral therapies. There is also a growing acceptance of addiction as a medical condition requiring specialized treatment, resulting in a shift from punitive approaches to more compassionate and evidence-based strategies. Additionally, the market has been driven by the rising prevalence of substance abuse disorders, particularly opioid addiction, and the increasing availability of substance abuse treatment centers and facilities, including telehealth services and virtual treatment options that have become popular during the COVID-19 pandemic.

Substance Abuse Treatment Market Report Highlights

Drug abuse segment is expected to dominate the global market within the projected period. Because drug abuse can harm the body parts such as heart, kidney, and liver damage, and may change behavior patterns, hallucinations, and memory loss. Which leads to addiction therapy.

Hospital segment holds the largest market share and will dominate the market over the projected period. Severe cases of drug abuse need to take to the hospital to provide necessary addiction treatment.

North America is anticipated to grow at the highest CAGR during the projected period, due to raising the prevalence of substance abuse disorders, increasing awareness, and growing government initiatives that propel the region’s growth.

The global key market players include INSYS Therapeutics, Teva Pharmaceutical, Sun Pharma, Glenmark, Sanofi Aventis, Sterinova, Apotex, BioCorRx, Opiant Technologies, Accord Healthcare, Mylan Laboratories, Cipla, LFB Group, Lupin, Amphastar Pharmaceuticals, and Sanquin.

Polaris Market Research has segmented the substance abuse treatment market report based on treatment type, end-use, and region:

Substance Abuse Treatment, Treatment Type Outlook (Revenue - USD Billion, 2019 - 2032)

Drug Abuse

Alcohol

Tobacco/Nicotine

Others

Substance Abuse Treatment, End-Use Outlook (Revenue - USD Billion, 2019 - 2032)

Hospitals

Clinics

Rehabilitation Centers

Others

Substance Abuse Treatment, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa